MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41598-025-06290-5

Медицинская библиотека · Scientific reports · 2025

Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes.

Brzdęk Michał, Zarębska-Michaluk Dorota, Rzymski Piotr, Lorenc Beata, Janocha-Litwin Justyna, Berak Hanna, Tomasiewicz Krzysztof, Sitko Marek, Mazur Włodzimierz, Janczewska Ewa, Dybowska Dorota, Klapaczyński Jakub, Parfieniuk-Kowerda Anna, Jaroszewicz Jerzy, Piekarska Anna, Flisiak Robert

СтатьяПеревод в очереди

Аннотация

The clinical and metabolic interactions between hepatitis C virus (HCV) infection and diabetes mellitus (DM) are well documented. The study aimed to compare HCV-infected patients with and without DM. The analysis included 18,968 patients treated with direct-acting antivirals (DAAs) between 2015 and 2023, whose data were collected retrospectively. In the study population, 2179 patients (11.5%) were diagnosed with DM. Compared to the non-diabetic population, they were male-dominated (p = 0.003), had a significantly higher proportion of patients aged ≥ 50 years (p < 0.001), and were more burdened with comorbidities (p < 0.001). The most common HCV genotype was 1b with a significantly higher prevalence in the diabetic group (p < 0.001). Liver disease advancement was higher in diabetic patients, with 17.9% advanced fibrosis and 48% cirrhosis compared to 13.2% (p < 0.001) and 21.8% (p < 0.001) in the non-diabetic population. The effectiveness of DAA therapy in patients with DM was significantly lower compared to the population without diabetes, both in intent-to-treat analysis 93.1% vs. 94.6%, p = 0.015, and per-protocol analysis 96.8% vs. 97.7%, p = 0.0128, however, logistic regression analysis did not confirm the role of diabetes as an independent predictor of treatment failure, suggesting that in the absence of other negative prognostic factors, DM alone does not reduce the chances of cure.

Для цитирования: Brzdęk Michał, Zarębska-Michaluk Dorota, Rzymski Piotr, Lorenc Beata, Janocha-Litwin Justyna, Berak Hanna, Tomasiewicz Krzysztof, Sitko Marek, Mazur Włodzimierz, Janczewska Ewa, Dybowska Dorota, Klapaczyński Jakub, Parfieniuk-Kowerda Anna, Jaroszewicz Jerzy, Piekarska Anna, Flisiak Robert. Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes.. Scientific reports. 2025. DOI: 10.1038/s41598-025-06290-5.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.